Overall, the current data indicate that PARP-1 might play a role in the mechanisms underlying leukodystrophies such as KD, X-ALD, or MLD based on the effects of PARP-1 inhibition on inflammatory and neuromodulatory mediators. Here, PARP1 is linked to leukodystrophy.